Japanese Pharmaceuticals & Biotech Most Popular Stocks

Innovacell

Market Cap: JP¥24.1b

Develops, manufactures, and sells cell therapy and regenerative medicine products.

Renascience

Market Cap: JP¥21.2b

Engages in the development and commercialization of pharmaceuticals and medical devices in Japan.

Astena Holdings

Market Cap: JP¥21.0b

Manufactures and sells medicine-related products in Japan.

AnGes

Market Cap: JP¥19.5b

Engages in the research and development of gene-based medicines.

StemRIM

Market Cap: JP¥19.0b

A biotechnology company, researches and develops regeneration-inducing medicine in Japan and internationally.

Fuso Pharmaceutical IndustriesLtd

Market Cap: JP¥18.2b

Manufactures and sells pharmaceuticals and medical equipment in Japan.

Pharma Foods International

Market Cap: JP¥16.5b

Engages in the development and sale of functional food ingredients in Japan.

CanBas

Market Cap: JP¥14.2b

A clinical stage biopharmaceutical company, engages in the basic research and clinical development of anti-cancer drugs.

RaQualia Pharma

Market Cap: JP¥13.2b

Engages in the research and development of pharmaceutical compounds worldwide.

ReproCELL

Market Cap: JP¥12.8b

Provides stem cell research and drug discovery services in Japan.

Stella Pharma

Market Cap: JP¥11.3b

Engages in the research, development, manufacturing, and distribution of pharmaceuticals.

Kubota Pharmaceutical Holdings

Market Cap: JP¥9.6b

Engages in the pharmaceutical and medical device business worldwide.

Wakamoto PharmaceuticalLtd

Market Cap: JP¥9.0b

Wakamoto Pharmaceutical Co.,Ltd. is engaged in the manufacture and sale of pharmaceuticals, medical devices, and health food in Japan.

CellSeed

Market Cap: JP¥9.0b

Engages in the cell sheet regenerative medicine business in Japan, the rest of Asia, and Europe.

Immuno-Biological Laboratories

Market Cap: JP¥8.9b

Engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide.

K PharmaInc

Market Cap: JP¥8.5b

Engages in the research, development, manufacture, and sale of regenerative medicines and pharmaceutical products in Japan.

Nano Holdings

Market Cap: JP¥8.3b

Researches, develops, produces, and sells pharmaceuticals using micellar nanoparticles technology in Japan.

Solasia Pharma K.K

Market Cap: JP¥8.2b

Develops, markets, imports, and exports pharmaceutical products and medical devices in Japan, China, South Korea, and internationally.

OncoTherapy Science

Market Cap: JP¥8.2b

Engages in research and development of anti-body drugs; and the genome analysis of cancer, liquid biopsy, and development of new immunotherapy in Japan.

MEDINET

Market Cap: JP¥7.3b

Operates as a contract development and manufacturing organization that provides regenerative medicine and cell therapy solutions in Japan.

Kidswell Bio

Market Cap: JP¥7.3b

Develops pharmaceutical products for the treatment of pediatric, pediatric, intractable, and Asia-endemic diseases in Japan.

BrightPath Biotherapeutics

Market Cap: JP¥6.9b

Engages in the development of cancer immunotherapy drugs in Japan.

Tsubota Laboratory

Market Cap: JP¥6.5b

Engages in the development and sale of pharmaceuticals and medical devices for the treatment of myopia, dry eyes, presbyopia, and brain diseases in Japan, China, France, and internationally.

Carna Biosciences

Market Cap: JP¥6.4b

A clinical-stage biopharmaceutical company, researches and develops drug therapies to treat unmet medical needs in Japan.

WDB coco

Market Cap: JP¥6.3b

Provides outsourcing and support services for pharmaceutical and medical device development in Japan.

CellSource

Market Cap: JP¥6.2b

Engages in the regenerative medicine-related businesses in Japan.

Chordia Therapeutics

Market Cap: JP¥6.1b

A biotech company, engages in research and development of anti-cancer drugs that targets RNA deregulation stress in Japan.

Noile-Immune Biotech

Market Cap: JP¥6.0b

Researches and develops CAR-T cells for novel cancer immunotherapies.

PRISM BioLabLTD

Market Cap: JP¥6.0b

Engages in the research and development of pharmaceuticals using its proprietary drug discovery platform technology, PepMetics Technology.

Precision System Science

Market Cap: JP¥5.8b

Engages in the development, manufacturing, and sale of automated systems/instruments, other physicochemical instruments, software, and other products in Japan.

Nippon Chemiphar

Market Cap: JP¥5.8b

Engages in the manufacture, sale, import, and export of ethical pharmaceuticals and diagnostic agents in Japan and internationally.

Chiome Bioscience

Market Cap: JP¥5.5b

Engages in the research and development of antibody drugs in Japan, Singapore, and internationally.

Cyfuse Biomedical K.K

Market Cap: JP¥5.2b

Develops, manufactures, and sells regenerative medicine-related products in Japan, Europe, and the United States.

J-Pharma

Market Cap: JP¥5.2b

J-Pharma Co., Ltd. is engaged in drug discovery and development, focusing on amino acid transporters as drug targets.

SymBio Pharmaceuticals

Market Cap: JP¥5.0b

Engages in the and development, manufacturing and sales of pharmaceuticals and other related operations in Japan and internationally.

Linical

Market Cap: JP¥4.7b

A global contract research organization, provides full spectrum of drug development services to pharmaceutical companies worldwide.